Fig. 3

Oral preventive medication regimens by line of therapy – CPRD Migraine Preventive Treatment User Cohort (N = 34,448)^a. ^aTreatments that comprise < 1% are not displayed, so the patient count is lower than the cohort size. CPRD: Clinical Practice Research Datalink; N: number of patients in total population. Clarification: (i) In the second column, fourth block from the top “Topiramate: 1,159” is stated, and (ii) in the third column, second block from the top “Amitriptyline + Gabapentin + Propranolol hydrochloride: 98” is stated.